Evidence map›Paper›PMID 38472610›Full record

ArticlePharmaceutical research2024

When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?

Yunjiao Wu, Karel Allegaert, Robert B Flint, Sebastiaan C Goulooze, Pyry A J Välitalo, Matthijs de Hoog, Hussain Mulla, Catherine M T Sherwin, Sinno H P Simons, Elke H J Krekels and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Pharmaceutical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
8.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Yunjiao WuDivision of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands.
Karel AllegaertDepartment of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Robert B FlintDepartment of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Sebastiaan C GouloozeLeiden Experts On Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands.
Pyry A J VälitaloSchool of Pharmacy, University of Eastern Finland, Yliopistonranta 1 C, 70210, Kuopio, Finland.
Matthijs de HoogDepartment of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
Hussain MullaDepartment of Pharmacy, University Hospitals of Leicester, Glenfield Hospital, Leicester, LE39QP, England.
Catherine M T SherwinDepartment of Pediatrics, Wright State University Boonshoft School of Medicine/Dayton Children's Hospital, One Children's Plaza, Dayton, OH, USA.
Sinno H P SimonsDepartment of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
Elke H J KrekelsDivision of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands.
Catherijne A J KnibbeDivision of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands.
Swantje VöllerDivision of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, The Netherlands. s.voller@lacdr.leidenuniv.nl.ORCID http://orcid.org/0000-0003-0587-2775
Leiden University · NLErasmus MC · NLErasmus MC - Sophia Children’s Hospital · NLGlenfield Hospital · GBUniversity of Eastern Finland · FIWright State University · US

Funding

China Scholarship Council 201907060018
6 · The paper itself

Abstract

aimsWhether and when glomerular filtration rate (GFR) in preterms catches up with term peers is unknown. This study aims to develop a GFR maturation model for (pre)term-born individuals from birth to 18 years of age. Secondarily, the function is applied to data of different renally excreted drugs.

methodsWe combined published inulin clearance values and serum creatinine (Scr) concentrations in (pre)term born individuals throughout childhood. Inulin clearance was assumed to be equal to GFR, and Scr to reflect creatinine synthesis rate/GFR. We developed a GFR function consisting of GFR

resultIn the GFR model, GFR

conclusionsGFR of preterm individuals catches up with term peers at around three years of age, implying reduced dosages of renally cleared drugs should be considered below this age.

Indexed as

Anti-Bacterial AgentsInulinBirth WeightChildCreatinineGlomerular Filtration RateHumansInfant, NewbornVancomycinAnti-Bacterial AgentsCreatinineInulinVancomycincreatinineglomerular filtration rateinulin clearancematurationpreterm neonates

Identifiers

PMID38472610
PMCPMC11024008
OpenAlexW4394759722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.